Document is current
Any future updates will be listed below
-
Authors
Csekő, Kata
Hargitai, Dóra
Draskóczi, Lilla
Kéri, Adrienn
Jaikumpun, Pongsiri
Kerémi, Beáta
Helyes, Zsuzsanna
Zsembery, Ákos
-
Funding
Funding for this research was provided by:
The role of neuro-inflammation in neurodegeneration: from molecules to clinics (EFOP-3.6.2-16-2017-00008, EFOP-3.6.2-16-2017-00008)
Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary (20765-3/2018/FEKUTSRTAT)
Human Resource Development Operational Program (EFOP-3.6.2-16-2017-00006 LIVE LONGER)
Economic Development and Innovation Operational Program (GINOP-2.3.2-15-2016-00048 STAY ALIVE)
Semmelweis University
- License Information
-
More Information
Article History
Received: 3 December 2021
Accepted: 29 March 2022
First Online: 7 April 2022
Declarations
:
: All procedures were performed in accordance with the 40/2013 (II.14.) Government Regulation on Animal Protection and Consideration Decree of Scientific Procedures of Animal Experiments and Directive 2010/63/EU of the European Parliament. They were approved by the Animal Welfare Committee of the University of Pécs and the National Scientific Ethics Committee on Animal Research of Hungary (licence No.: BA02/2000–4/2019 issued on 29 Jan 2019 by the Government Office of Baranya County). The study was carried out in compliance with the ARRIVE guidelines.
: Not applicable.
: Author Z. H. was employed by the company PharmInVivo Ltd. The company had no role in the design, execution, interpretation, or writing of the study. The remaining authors declare no conflict of interest.
